
Solna biotech and pharma directory
Solna is a life-science cluster in Sweden with 3 verified companies in this directory, spanning Therapeutics, Diagnostics. Its anchor companies include Elypta, Affibody, Biosergen. Every profile is hand-reviewed against leadership sources, a verified physical address, and regulatory certifications.
Where does this city read strongest?
Therapeutics (2) and Diagnostics (1). Most visible records: Biosergen, Affibody, and Elypta.
Which standards and public evidence are already visible?
ISO-13485 (1). Latest review: 22 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Solna.
Solna by category
Jump into a category page filtered to this country only.
Solna biotech and pharma directory
3 city records currently match the active filter.
Biosergen
SolnaSwedenTherapeutics
Solna biotech company developing innovative antifungal therapeutics for life-threatening invasive fungal infections from a Swedish listed-company base.
- Lead
- Tine Kold OlesenChief Executive Officer
- Scale
- Clinical-stage therapeutics platform
Affibody
SolnaSwedenTherapeutics
Solna protein-engineering company developing Affibody molecules for targeted therapeutics and molecular imaging from its Swedish operating base.
- Lead
- David BejkerPresident and CEO
- Scale
- Development-stage therapeutics platform
Elypta
SolnaSwedenDiagnostics
Solna molecular-diagnostics company developing metabolism-based liquid biopsy tests for earlier cancer detection and recurrence monitoring from the Karolinska campus.
- Lead
- Karl BergmanCEO
- Scale
- Diagnostics development platform
Frequently asked questions
- How many biotech companies are in Solna?
- Solna hosts 3 verified life-science companies in this directory — spanning Therapeutics, Diagnostics. The exact count appears in the page header above and updates with each directory refresh.
- What are the leading biotech companies in Solna?
- Solna's anchor companies include Elypta, Affibody, Biosergen. Each is hand-reviewed against primary leadership sources, a verified physical address, and regulatory certifications.
Briefs that mention Solna
Nordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefEuropean Anti-Infectives & AMR 2026: Antibacterials, Antifungals, Sepsis, and Pathogen Diagnostics
A practical map of the European anti-infectives and antimicrobial resistance sector in 2026 — Basilea (Cresemba, Zevtera), BioVersys, Biosergen, Modus Therapeutics, AlgiPharma, plus the rapid molecular diagnostics + AMR detection layer.
Open briefRead the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.
